«Tabes Dorsalis

Below is an extended Tabes Dorsalis patents listing. Click here to return to the Tabes Dorsalis main in depth entry.

Patents :
US Patent No.	Title
6770466	Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
7009056	Blockade of voltage dependent sodium channels
7026447	53 human secreted proteins
7034112	Methods for diagnosis and treatment of MDK1 signal transduction disorders
7041803	Galectin 11
7070803	Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine
7074403	Immunotherapy of autoimmune disorders using antibodies which target B-cells
7078186	Apoptosis related polynucleotides, polypeptides, and antibodies
7087754	Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists
7091315	Protein HDPBQ71
7098333	Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonists
6994857	Albumin fusion proteins
6951924	Antibodies against secreted protein HTEBYII
6946134	Albumin fusion proteins
6787541	Thieno-and furopyrimidine derivatives as A2A-receptor antagonists
6815534	Tissue plasminogen activator-like protease
6824993	Antibodies that bind human prostate specific G-protein receptor HPRAJ70
6828318	2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
6878806	Human secreted protein HTEEB42
6905688	Albumin fusion proteins
6919433	Antibodies to protein HPMBQ91
6926898	Albumin fusion proteins
6936688	Human chemokine beta-10 mutant polypeptides
6936691	Secreted protein HCE3C63
7109304	Humanized anti-CD19 antibodies
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7312318	Internalizing anti-CD74 antibodies and methods of use
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7381800	Antibodies to HBIMF63 polypeptide
7384949	Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists
7390637	Keratinocyte derived interferon
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7404969	Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7405219	Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists
7405320	Therapeutic and diagnostic conjugates for use with multispecific antibodies
7259249	Method for preparing conjugates of proteins and chelating agents
7238667	Albumin fusion proteins
7238660	Albumin fusion proteins
7141575	Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
7151164	Anti-CD20 antibodies and fusion proteins thereof and methods of use
7163797	50 human secreted proteins
7172751	D-amino acid peptides
7175988	Human G-protein Chemokine Receptor (CCR5) HDGNR10
7189690	Albumin fusion proteins
7196164	Secreted protein HHTLF25
7205139	Tissue plasminogen activator-like protease
7232667	Keratinocyte growth factor-2 polynucleotides
7235529	Brain-associated inhibitor of tissue-type plasminogen activator
7411051	Antibodies to HDPPA04 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.